Swiss Re refocuses risk management
The firm is tapping pharmaceutical player to bolster its research capabilities
Swiss Re refocuses risk management
INSURANCE NEWS
By Allie Sanchez
27 Feb 2017
After posting lower financial results for 2016, reinsurance firm Swiss Re announced that it is undertaking reforms in its research activities with the help of pharmaceutical company Novartis.

According to its latest financials, Swiss Re’s net income dropped 20% to $3.6 billion last year.

Want the latest insurance industry news first? Sign up for our completely free newsletter service now.

The Financial Times reports that chief executive Christian Mumenthaler is trying to reinvent the company into a “risk knowledge” firm to leverage in-house expertise from modelling natural catastrophes and other hazards in recent years.

The reinsurer’s CEO also said that a new “Swiss Re Institute” will initiate research in behavioural economics and the digitalization of insurance.


Related stories:
Insurer shrinks headcount by 10,000
Swiss Re sees net income slump by $1 billion
Free newsletter

We'll keep you up-to-date with the latest breaking news, cutting edge opinion, and expert analysis affecting both your business and the industry as whole.

Free newsletter

Our daily newsletter is FREE and keeps you up - to - date with the world of Insurance. Please complete the form below and click on subscribe for daily newsletters from IB US.